Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1989 Jun;42(6):629–633. doi: 10.1136/jcp.42.6.629

Lupus anticoagulant, anticardiolipin antibodies, and human immunodeficiency virus in haemophilia.

H Cohen 1, I J Mackie 1, N Anagnostopoulos 1, G F Savage 1, S J Machin 1
PMCID: PMC1141992  PMID: 2500459

Abstract

The prevalence of lupus anticoagulant, using the dilute Russell's viper venom time (DRVT), was determined in 22 patients with mild to severe haemophilia A to see if there was any association with the presence of viral disease. Twelve haemophiliacs (58%) were lupus anticoagulant positive, with a mean patient:control ratio of 1.24 (range 1.15-1.52, normal range 0.84-1.06 which partially corrected with lysed, washed platelets). Nine of these patients were IgG or IgM, or both, anticardiolipin antibody positive and nine were human immunodeficiency virus (HIV) antibody positive, but associations between lupus anticoagulant, anticardiolipin antibodies, and HIV antibody positivity were not significant. Mixing studies of normal plasma and immune depleted factor VIII deficient plasma showed that the DRVT ratio increased when the factor VIII concentration fell below 0.15 IU/ml. There was no significant association between plasma factor VIII concentration and positive DRVT results in haemophiliacs. The addition of porcine factor VIII concentrate produced no correction in eight of the 12 with DRVTs indicative of lupus anticoagulant, suggesting that these were prolonged by antiphospholipid activity. It is concluded that the presence of lupus anticoagulant and anticardiolipin antibodies in haemophiliacs may represent an antiphospholipid response to viraemic challenge, not only to HIV but also to other viral antigens, and that a very low factor VIII concentration may produce a false positive DRVT result.

Full text

PDF
629

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloom E. J., Abrams D. I., Rodgers G. Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA. 1986 Jul 25;256(4):491–493. [PubMed] [Google Scholar]
  2. Brien W., Inwood M., Denome G. Antiphospholipid antibodies in haemophiliacs. Br J Haematol. 1988 Feb;68(2):270–271. doi: 10.1111/j.1365-2141.1988.tb06207.x. [DOI] [PubMed] [Google Scholar]
  3. Canoso R. T., Zon L. I., Groopman J. E. Anticardiolipin antibodies associated with HTLV-III infection. Br J Haematol. 1987 Apr;65(4):495–498. doi: 10.1111/j.1365-2141.1987.tb04157.x. [DOI] [PubMed] [Google Scholar]
  4. Cohen A. J., Philips T. M., Kessler C. M. Circulating coagulation inhibitors in the acquired immunodeficiency syndrome. Ann Intern Med. 1986 Feb;104(2):175–180. doi: 10.7326/0003-4819-104-2-175. [DOI] [PubMed] [Google Scholar]
  5. Colaço C. B., Male D. K. Anti-phospholipid antibodies in syphilis and a thrombotic subset of SLE: distinct profiles of epitope specificity. Clin Exp Immunol. 1985 Feb;59(2):449–456. [PMC free article] [PubMed] [Google Scholar]
  6. Colaço C. B., Scadding G. K., Lockhart S. Anti-cardiolipin antibodies in neurological disorders: cross-reaction with anti-single stranded DNA activity. Clin Exp Immunol. 1987 May;68(2):313–319. [PMC free article] [PubMed] [Google Scholar]
  7. Gold J. E., Haubenstock A., Zalusky R. Lupus anticoagulant and AIDS. N Engl J Med. 1986 May 8;314(19):1252–1253. doi: 10.1056/NEJM198605083141912. [DOI] [PubMed] [Google Scholar]
  8. Harris E. N., Gharavi A. E., Patel S. P., Hughes G. R. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol. 1987 Apr;68(1):215–222. [PMC free article] [PubMed] [Google Scholar]
  9. Loizou S., McCrea J. D., Rudge A. C., Reynolds R., Boyle C. C., Harris E. N. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol. 1985 Dec;62(3):738–745. [PMC free article] [PubMed] [Google Scholar]
  10. Mackie I. J., Colaco C. B., Machin S. J. Familial lupus anticoagulants. Br J Haematol. 1987 Nov;67(3):359–363. doi: 10.1111/j.1365-2141.1987.tb02358.x. [DOI] [PubMed] [Google Scholar]
  11. Misra R., Venables P. J., Watkins R. P., Maini R. N. Autoimmunity to cardiolipin in infectious mononucleosis. Lancet. 1987 Sep 12;2(8559):629–629. doi: 10.1016/s0140-6736(87)93019-4. [DOI] [PubMed] [Google Scholar]
  12. Thiagarajan P., Pengo V., Shapiro S. S. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood. 1986 Oct;68(4):869–874. [PubMed] [Google Scholar]
  13. Trull A. K., Ebringer R., Panayi G. S., Colthorpe D., James D. C., Ebringer A. IgA antibodies to Klebsiella pneumoniae in ankylosing spondylitis. Scand J Rheumatol. 1983;12(3):249–253. doi: 10.3109/03009748309098543. [DOI] [PubMed] [Google Scholar]
  14. Weetman A. P., Gunn C., Hall R., McGregor A. M. Thyroid autoantigen-induced lymphocyte proliferation in Graves' disease and Hashimoto's thyroiditis. J Clin Lab Immunol. 1985 May;17(1):1–6. [PubMed] [Google Scholar]
  15. Zwaal R. F., Hemker H. C. Blood cell membranes and haemostasis. Haemostasis. 1982;11(1):12–39. doi: 10.1159/000214638. [DOI] [PubMed] [Google Scholar]
  16. el-Roiey A., Sela O., Isenberg D. A., Feldman R., Colaco B. C., Kennedy R. C., Shoenfeld Y. The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6) Id and anti-polynucleotide activity. Clin Exp Immunol. 1987 Mar;67(3):507–515. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES